Aethlon Medical Inc

Aethlon Medical Inc. is a medical therapeutic company based in San Diego, California. The company employs 23 people and generates $0.23 million in annual revenue. Aethlon Medical is dedicated to developing the Hemopurifier, a cutting-edge immunotherapeutic device positioned to revolutionize the treatment of cancer and life-threatening viral infections. The Hemopurifier utilizes a proprietary lectin-based technology to selectively remove harmful entities, including viruses and exosomes, from the bloodstream. This innovative approach holds immense promise for patients battling advanced or metastatic cancer, particularly those who have not responded to conventional treatments or experience adverse reactions to standard therapies. Additionally, the Hemopurifier is being investigated for its potential in treating life-threatening viral infections lacking effective treatments. The U.S. Food and Drug Administration (FDA) has recognized the Hemopurifier's groundbreaking potential by granting it Breakthrough Device designations for both cancer and life-threatening viral infections. This designation reflects the device's significant potential to provide substantial improvements in the diagnosis or treatment of these serious conditions. For more information about Aethlon Medical Inc. and the Hemopurifier, please visit their website at aethlonmedical.com.